GV20 Therapeutics

Newton · $1.5M raised

Headquarters
Newton
Business Model
B2B
Website
gv20tx.com
Total Funding
$1.5M
Last Round
$1.5M Series BOct 2021
Rounds
2

About

GV20 Therapeutics is a clinical-stage, AI-powered biotherapeutics company developing next-generation cancer treatments. Its proprietary STEAD platform integrates massive B-cell repertoire data, -omics data, and advanced AI models to uncover novel tumor targets and antibodies that elude other approaches. The pipeline includes best-in-class and first-in-class monoclonal and bispecific antibodies plus antibody-drug conjugates, led by GV20-0251 — a fully human antibody targeting the novel immune checkpoint IGSF8 — which advanced from target discovery to an IND in three years and is now in Phase 1/2a trials.

Summary

GV20 Therapeutics is a Biotech company based in Newton. It has raised $1.5M in total across 2 rounds, most recently a $1.5M Series B round in Oct 2021. Investors include Coatue Management, IDG Capital and 3W Investment.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BOct 2021

Sign up to see all 2 rounds

Seed through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

GV20 Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/gv20-therapeutics"><img src="https://indexed.vc/api/badge/company/gv20-therapeutics" alt="GV20 Therapeutics on Indexed.vc" width="260" height="76" /></a>